Related Experiment Video
Updated: Apr 13, 2026

16:11
Implantation of the Syncardia Total Artificial Heart
Published on: July 18, 2014
35.2K
Cardiac transplantation after HeartMate3
Maksym Rzhanyi1, Gustavo Woll2, Elena Sandoval Martínez3
1М.M. Amosov National Institute of Cardio-vascular Surgery, Kyiv, Ukraine.
Multimedia Manual of Cardiothoracic Surgery : MMCTS
|September 24, 2024
Summary
Heart transplantation is crucial for end-stage heart failure. This tutorial details removing a HeartMate 3 left ventricular assist device during heart transplant surgery.
Area of Science:
- Cardiovascular Surgery
- Transplantation Medicine
- Mechanical Circulatory Support
Background:
- Heart transplantation is the optimal treatment for end-stage heart failure.
- Limited donor hearts necessitate alternative strategies like mechanical circulatory support.
- Intracorporeal left ventricular assist devices present surgical challenges during heart transplantation.
Discussion:
- This video tutorial presents a surgical strategy for concomitant orthotopic heart transplantation in a patient with a HeartMate 3 left ventricular assist device.
- The focus is on the specific technique for removing the HeartMate 3 device implanted via sternotomy.
- The described approach aims to streamline the complex procedure of heart transplantation with prior device implantation.
Key Insights:
- A systematic surgical approach is vital for successful heart transplantation in patients with left ventricular assist devices.
- Efficient removal of the HeartMate 3 device is critical to minimize operative time and complications.
- This technique facilitates combined heart transplantation and device explantation.
Outlook:
- Further refinement of surgical techniques for device removal can improve outcomes in heart transplant recipients.
- Advancements in mechanical circulatory support may lead to more integrated approaches with transplantation.
- This strategy offers a valuable resource for surgeons managing complex heart failure cases.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
801
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
801
Cardiomyopathy III: Hypertrophic Cardiomyopathy
775
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
775
Cardiomyopathy V: Interprofessional Care
702
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
702

